This is the first book to comprehensively combine cutting edge information about the pathophysiology and novel therapeutic strategies in multiple sclerosis. The topics range from responses of the immune system to brain damage processes, as well as from molecular mechanisms to novel therapeutic strategies. The editors are internationally known for their basic and clinical research and first rate authors guarantee detailed and up-to-date coverage.
Sprache
Verlagsort
Zielgruppe
Maße
Höhe: 240 mm
Breite: 170 mm
Dicke: 170 mm
ISBN-13
978-3-527-31469-0 (9783527314690)
Copyright in bibliographic data is held by Nielsen Book Services Limited or its licensors: all rights reserved.
Schweitzer Klassifikation
Since 2002 Frauke Zipp has served as head of the newly founded Institute of Neuroimmunology at the Charite, University Medicine Berlin. She received her post--doctoral training at the Max--Planck Institute of Biochemistry, Martinsried, and the National Institutes of Health (Division of Neuroimmunology), Bethesda. Hugh Perry has been Professor of Experimental Neuropathology at the University of Oxford from 1996 to 1998 before taking over the same position at the University of Southampton where he is now heading the CNS Inflammation Group.
Herausgeber*in
Charite, University Medicine Berlin,
Department of Neuropathology, University of Goett
IMMUNE REGULATION AND EFFECTOR DAMAGE MECHANISMS T cellular immune response -- from mouse to human (Wekerle) Tolerance towards myelin and its breakdown (Liblau) Antigen presentation and lymphocyte response in EAE/ MS. (Becher, Goebels) Transmigration of immune cells through the blood brain barrier (Ransohoff) Dysmyelination and remyelination in the central nervous system (Nave) Immune--mediated damage mechanisms in the brain (Owens) Axonal and neuronal pathology in MS (Trapp) Brain damage and its mechanisms (Perry) CLINICAL RESEARCH AND NOVEL THERAPEUTIC STRATEGIES New MRI strategies to understand the pathology of MS (Miller) Protection of oligodendrocytes in the inflamed brain (Gold) Repair in the brain via stem cell approaches in EAE/MS (Martino) Clinical MS (Tabira) Treatment effects in the MRI (Barkhof) Novel therapeutic strategies and the transfer into the clinics (Zipp)
